<DOC>
	<DOCNO>NCT01973647</DOCNO>
	<brief_summary>Difficulty fall asleep , stay asleep poor quality sleep ( insomnia ) common people chronic obstructive pulmonary disease . Insomnia relate great mortality , four time risk mortality sleep time &lt; 300 minute . Insomnia also relate great morbidity , 75 % great health care cost people without insomnia . However , insomnia medication use caution COPD due potential adverse effect . Common feature COPD dyspnea , chronic inflammation , anxiety depression also affect insomnia interfere therapy outcome . While cognitive behavioral therapy insomnia ( CBT-I ) , therapy provide guidance change unhelpful sleep-related belief behavior , effective people primary insomnia people chronic illness , efficacy mechanism action therapy yet unclear people insomnia COPD . The objective application rigorously test efficacy two component insomnia therapy - CBT-I COPD education ( COPD-ED ) - people coexist insomnia COPD , identify mechanism responsible therapy outcome . The central hypothesis CBT-I COPD-ED positive , lasting effect objectively subjectively measure insomnia fatigue . The rationale propose study efficacy mechanisms CBT-I COPD-ED known , new innovative approach insomnia coexist COPD develop , thereby lead longer , high quality productive life people COPD , reduce societal cost due effect insomnia . The investigator plan test central hypothesis complete randomize controlled comparison CBT-I , COPD-ED non-COPD , non-sleep health education attention control ( AC ) use highly efficient 4-group design . Arm 1 comprises 6 weekly session CBT-I+AC ; Arm 2=6 session COPD-ED+AC ; Arm 3=CBT-I+COPD-ED ; Arm 4=AC . This design allow completion follow Specific Aims : 1 . Determine efficacy individual treatment component , CBT-I COPD-ED , insomnia fatigue . 2 . Define mechanistic contributor outcomes CBT-I COPD-ED . The research propose application innovative represent new substantive departure usual insomnia therapy , namely test traditional CBT-I education enhance outcome .</brief_summary>
	<brief_title>A Behavioral Therapy Insomnia Co-existing With COPD</brief_title>
	<detailed_description>The investigator plan test central hypothesis complete randomize controlled comparison CBT-I , COPD-ED non-COPD , non-sleep health education attention control ( AC ) use highly efficient 4-group design . Arm 1 comprises 6 weekly session CBT-I+AC ; Arm 2=6 session COPD-ED+AC ; Arm 3=CBT-I+COPD-ED ; Arm 4=AC . This design allow completion follow Specific Aims : 1 . Determine efficacy individual treatment component , CBT-I COPD-ED , insomnia fatigue . 2 . Define mechanistic contributor outcomes CBT-I COPD-ED .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>mild severe COPD . age â‰¥ 45 year age major healthproblems . clinically stable time enrollment study . insomnia . Exclusion criterion : evidence restrictive lung disease asthma . pulse oximetry read &lt; 90 % rest &lt; 85 % night &gt; 5 min . evidence major sleep disorder insomnia . hypnotic use . acute respiratory infection within previous 2 month . presence potentially debilitate disease cancer , congestive heart failure , kidney disease , liver failure cirrhosis ; evidence alcohol drug abuse , musculoskeletal degenerative nerve disease . selfreported current diagnosis major depression psychiatric disease Hospital Anxiety Depression Scale ( HADS ) depression score &gt; 11. currently participate pulmonary rehabilitation .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>insomnia</keyword>
	<keyword>cognitive behavioral therapy</keyword>
	<keyword>COPD</keyword>
	<keyword>fatigue</keyword>
</DOC>